 Join us every Tuesday for Profit With the Pros, as we share some of our favorite stock market reports, articles, research, and trends. We'll curate a fresh batch of free, top-tier content from our exceptional team of traders, analysts, and editors, constructed to help you keep your portfolio at the top of its game. As a new administration gears up to return to the White House, significant policy changes are expected, including in the healthcare and food industries. Lucky for us, Schaeffer's Senior Quantitative Analyst Rocky White has pulled the best 25 stocks to buy in the month of January, historically. Using data from the past 10 years, take a look at which stocks will be the safest buys for your 2025 portfolio, including one outperforming food chain that looks overdue for a pop. 3 SPX Factors to Watch as the Calendar TurnsSenior V.P. of Research Todd Salamone boasts over 29 years of options trading experience, with appearances on CNBC, Bloomberg Television, Fox Business Network to go with quotes in The Wall Street Journal, Reuters, and the Associated Press. His Monday Morning Outlook is the perfect road map for traders that want to hit the ground running at the start of each trading week. In his last outlook of 2024 (and first look at 2025!), Todd weighs mounting S&P 500 chart support with elevated short interest. 3 Airline Stocks to Watch as Travel Data BoomsIt was a busy year for airlines as travel picked up. In fact, per the U.S. Department of Transportation, the top 10 travel days in the Transportation Security Administration's (TSA) long history all came in 2024. With continued momentum into this coming year, we took a look at three airline stocks that are fresh off recent peaks. Avoid These 25 Stocks to Start the New YearAs we kick off the New Year, it's time to take a closer look at the stocks you might want to avoid. Based on a decade of data, we've compiled a list of the 25 worst-performing stocks in January — and topping the list is none other than vaccine giant Pfizer (PFE). With President-elect Donald Trump set to take office and Robert F. Kennedy Jr. tapped to head the Department of Health and Human Services, vaccine stocks are already feeling the heat. PFE, in particular, has a track record of starting the year on a sour note, making it one to watch -- but not necessarily one to own — next month.  Schaeffer's Investment Research | 5151 Pfeiffer Road, Cincinnati, OH 45242    |
Post a Comment
Post a Comment